EYESW (Second Sight Medical Products) Asset Impairment Charge : $0.00 Mil (TTM As of Jun. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Second Sight Medical Products Asset Impairment Charge?

Second Sight Medical Products's Asset Impairment Charge for the three months ended in Jun. 2022 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2022 was $0.00 Mil.

Second Sight Medical Products Asset Impairment Charge Historical Data

The historical data trend for Second Sight Medical Products's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Second Sight Medical Products Asset Impairment Charge Chart

Second Sight Medical Products Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Asset Impairment Charge

Get a 7-Day Free Trial

-0.14

0.11

Second Sight Medical Products Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Second Sight Medical Products Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Second Sight Medical Products Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Second Sight Medical Products's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Second Sight Medical Products Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Second Sight Medical Products Inc (NAS:EYESW) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

13170 Telfair Avenue, Sylmar, CA, USA, 91342

Website

https://www.secondsight.com

Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.